FDA Warning Letter — Adarsh Daswani, M.D.

Case 648606 — FEI 3017716431

The FDA took a Warning Letter action against Adarsh Daswani, M.D. on December 14, 2022 (La Palma, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Adarsh Daswani, M.D.
Date
December 14, 2022
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
La Palma, CA (United States)